Claim 50% Off TipRanks Premium and Invest with Confidence
- Unlock hedge-fund level data and powerful investing tools designed to help you make smarter, sharper decisions
- Stay ahead of the market with the latest news and analysis so your portfolio is always positioned for maximum potential
An update from TherapeuticsMD ( (TXMD) ) is now available.
TherapeuticsMD, Inc. reported a reduced net loss for Q3 2024, with operating expenses also declining due to its shift to a royalty-based business model. The company is exploring strategic alternatives, including potential mergers or acquisitions, but has not committed to any specific actions. Their cash reserves stand at $5 million, as they continue to focus on maximizing shareholder value amid a volatile stock environment.
See more data about TXMD stock on TipRanks’ Stock Analysis page.